Specific price of fezolinetant in 2026

Against the background that domestic patients are increasingly paying attention to non-hormonal treatments for menopause, the price and purchasing channels of Fezolinetant have become one of the hotly discussed topics. It should be clear that the drug has not yet been officially launched in China, so domestic patients cannot purchase it directly through regular hospitals or pharmacies for the time being. This current situation has also made its overseas market price, acquisition methods and differences between different versions become information that patients and family members pay close attention to.

According to overseas public information, the original research version of Fezonatant has been marketed in some countries and regions. The common specifications are45 mg and 30 tablets, which can usually meet the treatment needs for one month. According to overseas pharmacies and public quotation information, the price of each box is mostly in the range of more than 600 US dollars, which is equivalent to more than 3,000 yuan in RMB. The specific amount will be affected by exchange rate fluctuations, sales channels and differences in the local medical system. For patients who require long-term medication, this price level is also regarded as a mid- to high-priced new prescription drug overseas.

Against this background, non-original versions of products have also appeared in some overseas markets, such as generic versions produced by pharmaceutical companies such as Lucius in Laos. Judging from the disclosed information, this type of product is consistent with the original drug in terms of drug ingredients and dosage design, and the main difference is reflected in the price. The generic version of the same specifications may be sold for more than 900 yuan per box. Compared with the original drug, it has obvious economic advantages, so it has attracted attention among some patient groups.

It should be pointed out that whether it is the original drug or a generic version, fezonatant belongs to the category of prescription drugs, and overseas it usually requires a doctor’s evaluation before issuing a prescription. This regulation reflects its professional attributes as a centrally acting drug and also emphasizes the importance of standardized medication use. For domestic patients, before it is officially introduced, obtaining relevant information should focus more on understanding rather than blindly taking medication on their own.

Reference: https://www.astellas.com/content/dam/astellas-com/global/en/documents/veozah_usppi.pdf